Company Cannassure Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
Business Summary
Sales per Business
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Cannabis
67.6
%
| 25 | 74.6 % | 7 | 67.6 % | -70.52% |
Services
32.4
%
| 9 | 25.4 % | 4 | 32.4 % | -58.40% |
Sales per region
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 34 | 100.0 % | 11 | 100.0 % | -67.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 30/03/22 |
Nir Peles
CHM | Chairman | 51 | 03/12/18 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 25/06/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 03/12/18 |
Nir Peles
CHM | Chairman | 51 | 03/12/18 |
Varda Kalal
BRD | Director/Board Member | 56 | 13/02/22 |
Yaron Cherny
BRD | Director/Board Member | 54 | 28/08/22 |
Ron Wolman
BRD | Director/Board Member | 44 | 21/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,232,208 | 1,822,925 ( 81.66 %) | 0 | 81.66 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+47.74% | 275M | |
+30.93% | 274M | |
+48.84% | 195M | |
-14.29% | 145M | |
+57.96% | 142M | |
-31.21% | 141M | |
+147.89% | 140M | |
-7.69% | 80.05M | |
+150.00% | 75.33M |